'Holding onto life': Ontario cystic fibrosis patients await access to life-saving drug just approved by Health Canada
After just one day as part of a trial for a genetic modulator medication for cystic fibrosis patients, Madi Vanstone knew it was working.
“Her quality of life was horrible,” Beth Vanstone, Madi’s mother, told CTV News Toronto Tuesday.
“I don't exaggerate when I say that she spent probably 90 per cent of her time on the couch with a blanket and just not feeling well. She missed 96 days of school in Grade 6.”
After just one day on the trial drug, Kalydeco, Madi could breathe through her nose — something she didn’t even know was possible until that day.
“She started to gain weight … her lung function went from 70 per cent to 115 per cent of expected value in just 30 days,” Vanstone said.
Madi performed so well on Kalydeco that in 2019 she was able to traverse the Great Wall of China with her mother, raising more than $30,000 for Cystic Fibrosis Canada.
“It was a tribute to her newfound health,” Vanstone said.
Beth and Madi Vanstone on the Great Wall of China (Provided by Beth Vanstone)
Cystic fibrosis is the most common fatal genetic disease in children and young adults in Canada. The disease impacts the patients’ digestive and respiratory systems until the lungs eventually stop working. It can be caused by over 2,000 different variations of genetic mutations, Vanstone said.
While life-changing for Madi, Kalydeco doesn’t work as efficiently for everyone with cystic fibrosis. In fact, it is only effective for three to four per cent of the cystic fibrosis community, as it targets only two per cent of genetic mutations causing CF.
A more effective, alternate genetic modulator, Trikafta, was introduced into the American market in 2019. Research shows that Trikafta impacts 90 per cent of the cystic fibrosis community, as opposed to Kalydeco’s three to four per cent.
“Trikafta is the golden goose. [It’s] hitting it out of the park. People have come off of life support and out of their hospital beds and are back to work,” Vanstone said.
Within 90 days of introduction, the U.S. Food and Drug Administration had Trikafta on the shelves, available to American CF patients to purchase, but that wasn’t the case in Canada.
Since Trikafta arrived on the U.S. market in 2019, the Vanstones, alongside many other families and patients, have been lobbying Health Canada to approve the drug.
“You have to think that in October 2019, [Trikafta] was in the hands of patients in the U.S. and we're in June 2021 and we're still waiting to get access,” Vanstone said.
“We had to lobby the federal government for like, a year, probably, in order to get them to let Trikafta to come in.”
On Friday, June 18, Health Canada announced its approval for Trikafta.
“We're celebrating huge, don't get me wrong, but we still have another step to get it into patients' hands, because right now, people are literally holding on to life in order to get this drug,” Vanstone said.
CEO and President of Cystic Fibrosis Canada, Kelly Grover, called the moment "a special day for [the cystic fibrosis] community."
“Together we have been fighting hard for access to these medications. Thousands of letters and signatures and hundreds of meetings later, we are finally seeing the progress our community deserves,” said Grover in a release on the announcement.
Ottawa’s announcement means doctors can now prescribe Trikafta to Canadian patients. Although, with the drug costing approximately $300,000 USD a year per patient, provincial governments now need to negotiate pricing with manufacturer Vertex before getting the drug onto shelves and into the hands of CF patients across the country.
“I’ve been proud to work alongside people like Beth and Madi Vanstone, and Sasha Haughian and Jamie Larocque, who have been tireless in their efforts to access these innovative drugs.” Simcoe-Grey MPP Jim Wilson said in a release.
“Much of the credit for this progress goes to families in our region who have fought long and hard for these life-saving drugs."
Wilson said the ball is “now in Doug Ford’s court.”
“I am confident the government of Ontario will live up to its promise to list these drugs on the Ontario Drug Benefit Formulary and quickly make them available to patients,” he said.
When reached for comment, the Ontario Ministry of Health said that Ontario is looking forward to "continuing existing discussions with Vertex."
"Ontario recognizes that the cystic fibrosis community is anxious for access to new and effective treatments such as Trikafta ... These steps are a vital part of the overall process to ensure that drug treatments entering the Canadian market are safe, effective and provide value," spokesperson Bill Campbell told CTV News Toronto Wednesday.
Vanstone hopes that provinces act quickly in recognizing the importance of getting Trikafta into patients' hands, adding that many are “holding onto life” in the meantime.
“The CF community has worked tirelessly for over 10 years to get to this point,” Vanstone said.Whe
“We hope that the provinces will recognize [our work] and add this drug to their formulary so that patients can put their shoulders down and live their best lives now. We deserve it.
CTVNews.ca Top Stories
B.C. seeks ban on public drug use, dialing back decriminalization
The B.C. NDP has asked the federal government to recriminalize public drug use, marking a major shift in the province's approach to addressing the deadly overdose crisis.
More than 115 cases of eye damage reported in Ontario after solar eclipse
More than 115 people who viewed the solar eclipse in Ontario earlier this month experienced eye damage after the event, according to eye doctors in the province.
Orca calf that was trapped in B.C. lagoon for weeks swims free
An orca whale calf that has been stranded in a B.C. lagoon for weeks after her pregnant mother died swam out on her own early Friday morning.
Last letters of pioneering climber who died on Everest reveal dark side of mountaineering
George Mallory is renowned for being one of the first British mountaineers to attempt to scale the dizzying heights of Mount Everest during the 1920s. Nearly a century later, newly digitized letters shed light on Mallory’s hopes and fears about ascending Everest.
Sophie Gregoire Trudeau on navigating post-political life, co-parenting and freedom
Sophie Gregoire Trudeau says there is 'still so much love' between her and Prime Minister Justin Trudeau, as they navigate their post-separation relationship co-parenting their three children.
'I was scared': Ontario man's car repossessed after missing two repair loan payments
An Ontario man who took out a loan to pay for auto repairs said his car was repossessed after he missed two payments.
Trump's lawyers try to discredit testimony of prosecution's first witness in hush money trial
Donald Trump's defence team attacked the credibility Friday of the prosecution's first witness in his hush money case, seeking to discredit testimony detailing a scheme between Trump and a tabloid to bury negative stories to protect the Republican's 2016 presidential campaign.
U.S. flight attendant indicted in attempt to record teen girl in airplane bathroom
An American Airlines flight attendant was indicted Thursday after authorities said he tried to secretly record video of a 14-year-old girl using an airplane bathroom last September.
Powerful tornado tears across Nebraska, weather service warns of 'catastrophic' damage
Devastating tornadoes tore across parts of eastern Nebraska and northeast Texas Friday as a multi-day severe thunderstorm event ramped up in the central United States.